HomeNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
Nakaraang pagsara
$0.72
Sakop ng araw
$0.67 - $0.72
Sakop ng taon
$0.36 - $9.08
Market cap
3.34M USD
Average na Volume
411.32K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.44M | -1.61% |
Gastos sa pagpapatakbo | 2.65M | 12.46% |
Net na kita | -1.21M | 31.02% |
Net profit margin | -49.65 | 29.89% |
Kita sa bawat share | -0.59 | 95.41% |
EBITDA | -1.05M | -53.58% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 776.00K | -77.65% |
Kabuuang asset | 3.88M | -69.83% |
Kabuuang sagutin | 2.80M | -51.76% |
Kabuuang equity | 1.07M | — |
Natitirang share | 4.89M | — |
Presyo para makapag-book | 3.26 | — |
Return on assets | -68.00% | — |
Return on capital | -142.34% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.21M | 31.02% |
Cash mula sa mga operasyon | -2.06M | -466.21% |
Cash mula sa pag-invest | -2.00K | -100.00% |
Cash mula sa financing | 2.09M | 462.05% |
Net change in cash | 26.00K | 102.13% |
Malayang cash flow | -1.48M | -433.66% |
Tungkol
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.
and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Itinatag
2000
Headquarters
Website
Mga Empleyado
25
